Podowart
Podowart

50.2
A generic medicine indicated for women's health. Addresses abnormal skin growth by interrupting cellular replication at the site of application.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Podophyllum resin, Benzoin, Aloe vera
Reference Brand
Podophyllin
Product Origin
Generic Brand
Product Manufacturer
Wallace Pharmaceuticals
Product Form
Topical Solution
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Keratolytic Agent
Pharmacological Class
Topical Antimitotic
Manufacturer Description
Intended to relieve external skin warts to support healthy tissue regeneration and target cellular replication.
Mechanism of Action
Arrests cell division in metaphase by binding to microtubules, causing necrosis and erosion of the wart tissue.
Route of Administration
Topical
Onset Time
24–48 hours
Contraindications
Pregnancy, Diabetes mellitus, Broken or bleeding skin
Severe Adverse Events
Severe systemic podophyllin toxicity — requires immediate medical attention
Common Side Effects
Local skin redness, Burning sensation
Uncommon Side Effects
Skin peeling, Ulceration, Pain at application site
Pregnancy Safety Warnings
TGA Category X: Highly contraindicated. Embryotoxic and teratogenic. Do not use. Breastfeeding: Avoid.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Information related to Podowart is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Antidepressant Tablets - Cymbalta Australia